Method for treating kidney stones
AssigneeAdria Laboratories, Inc.
InventorRichard L. Wolgemuth
Life of this patent
Estimating the term…
Abstract
A method for decreasing urinary calcium content which comprises orally administering to a person whose urine contains insoluble calcium containing precipitates or has a propensity for forming calcium containing precipitates, an effective amount of an agent selected from water-soluble vinylbenzenesulfonic acid polymers and the nontoxic pharmaceutically acceptable salts thereof.
Claims2
A treatment for decreasing urinary calcium content which comprises orally administering to a host in need of such treatment, a therapeutically effective amount of an agent selected from water-soluble vinylbenzenesulfonic acid polymers having a viscosity average molecular weight in the range of from about 50,000 to about 500,000 and containing less than 5% by weight of polymers having a molecular weight of less than 20,000, wherein the polymers have from about 70 to over 90% molar monosulfonation and the nontoxic pharmaceutically acceptable salts thereof.
A treatment for decreasing urinary calcium content which comprises orally administering to a hose in need of such treatment, a therapeutically effective amount of a vinylbenzenesulfonic acid homopolymer having a viscosity average molecular weight range of from about 50,000 to about 500,000 and containing less than 5% by weight of polymers having a molecular weight of less than 20,000, having repeating units of the formula ##STR3## wherein the polymer has from about 70 to over 90% molar monosulfonation and nontoxic pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.